Human immunodeficiency virus neutralizing antibodies
US11655285B2 · kind B2 · utility
0Cited by
26References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 3, 2020 |
| Grant date | May 23, 2023 |
| Priority date | — |
| Expiry date | Jul 5, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/94
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides novel anti-HIV antibodies with improved therapeutic properties, related pharmaceutical compositions, and methods of use thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.